[go: up one dir, main page]

ATE114114T1 - Verwendung von benzimidazol-derivaten als antibakterielle mittel. - Google Patents

Verwendung von benzimidazol-derivaten als antibakterielle mittel.

Info

Publication number
ATE114114T1
ATE114114T1 AT90301256T AT90301256T ATE114114T1 AT E114114 T1 ATE114114 T1 AT E114114T1 AT 90301256 T AT90301256 T AT 90301256T AT 90301256 T AT90301256 T AT 90301256T AT E114114 T1 ATE114114 T1 AT E114114T1
Authority
AT
Austria
Prior art keywords
antibacterial agents
benzimidazole derivatives
stands
hydrogen
campylobacter
Prior art date
Application number
AT90301256T
Other languages
English (en)
Inventor
Tomoyuki Iwahi
Hiroshi Satoh
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26370930&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE114114(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ATE114114T1 publication Critical patent/ATE114114T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT90301256T 1989-02-10 1990-02-06 Verwendung von benzimidazol-derivaten als antibakterielle mittel. ATE114114T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3237489 1989-02-10
JP23923389 1989-09-15

Publications (1)

Publication Number Publication Date
ATE114114T1 true ATE114114T1 (de) 1994-12-15

Family

ID=26370930

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90301256T ATE114114T1 (de) 1989-02-10 1990-02-06 Verwendung von benzimidazol-derivaten als antibakterielle mittel.

Country Status (10)

Country Link
US (1) US5013743A (de)
EP (1) EP0382489B1 (de)
AT (1) ATE114114T1 (de)
CA (1) CA2009741C (de)
DE (1) DE69014141T2 (de)
DK (1) DK0382489T3 (de)
ES (1) ES2066120T3 (de)
FI (2) FI100168B (de)
GR (1) GR3014973T3 (de)
NO (1) NO900639L (de)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5338723A (en) * 1989-10-13 1994-08-16 Merck & Co., Inc. Fibrinogen receptor antagonists
AU8445791A (en) * 1990-09-14 1992-04-15 Byk Gulden Lomberg Chemische Fabrik Gmbh Use of pyridylmethylsulphinyl-1h-benzimidazole derivates in the treatment of illnesses caused by helicobacter bacteria
TW209174B (de) * 1991-04-19 1993-07-11 Takeda Pharm Industry Co Ltd
TW276996B (de) * 1992-04-24 1996-06-01 Astra Ab
US5504082A (en) * 1992-06-01 1996-04-02 Yoshitomi Pharmaceutical Industries, Ltd. Pyridine compound and pharmaceutical compostions
BR9306702A (pt) * 1992-07-08 1998-12-08 Monsanto Co Benzimidazóis para aliviar úlceras estomacais em suínos
EP0652751B1 (de) * 1992-07-28 1996-10-23 Astra Aktiebolag Injizierbares Arzneimittel und Satz, die Omoprazol oder verwandte Verbindungenenthalten
ATE137969T1 (de) * 1992-08-21 1996-06-15 Eisai Co Ltd Benzimidazolverbindungen als antibiotika gegen campylobacter pylon
AU5699594A (en) * 1992-12-10 1994-07-04 Byk Gulden Lomberg Chemische Fabrik Gmbh Use of alkylthiopyridines for controlling helicobacter bacteria
JPH06298611A (ja) * 1993-04-16 1994-10-25 Nippon Chemiphar Co Ltd 抗菌剤
ATE198887T1 (de) * 1993-06-29 2001-02-15 Byk Gulden Lomberg Chem Fab Substituierte arylthioalkylthiopyridine
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6645988B2 (en) * 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US8071128B2 (en) * 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
WO1999036422A1 (en) 1998-01-14 1999-07-22 The Uab Research Foundation Methods of synthesizing and screening inhibitors of bacterial nad synthetase enzyme, compounds thereof, and methods of treating bacterial and microbial infections with inhibitors of bacterial nad synthetase enzyme
US6861448B2 (en) * 1998-01-14 2005-03-01 Virtual Drug Development, Inc. NAD synthetase inhibitors and uses thereof
FI104384B (fi) 1998-06-05 2000-01-14 Valmet Corp Laitteisto ja menetelmä viiraveden ja tuoremassan sekoittamiseksi viirakaivon jälkeisessä kanavassa
EP1310252A4 (de) 2000-08-18 2009-06-10 Takeda Pharmaceutical Injektionen
WO2003024957A1 (en) * 2001-09-18 2003-03-27 Zeria Pharmaceutical Co., Ltd. Benzimidazole derivatives
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
CA2472103A1 (en) * 2002-01-25 2003-08-07 Santarus, Inc. Transmucosal delivery of proton pump inhibitors
US8367111B2 (en) * 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
US20040248942A1 (en) * 2003-02-20 2004-12-09 Bonnie Hepburn Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
US20050220870A1 (en) * 2003-02-20 2005-10-06 Bonnie Hepburn Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
US8993599B2 (en) * 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
JP2006528182A (ja) * 2003-07-18 2006-12-14 サンタラス インコーポレイティッド 薬学的製剤および酸に起因する消化器疾患の治療法
AR045062A1 (es) * 2003-07-18 2005-10-12 Santarus Inc Formulaciones farmaceuticas para inhibir la secrecion de acido y metodos para preparar y utilizarlas
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
AU2005213472A1 (en) * 2004-02-10 2005-08-25 Santarus, Inc. Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory agent
WO2005117870A2 (en) * 2004-04-16 2005-12-15 Santarus, Inc. Combination of proton pump inhibitor, buffering agent, and prokinetic agent
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20060024362A1 (en) * 2004-07-29 2006-02-02 Pawan Seth Composition comprising a benzimidazole and process for its manufacture
US8747895B2 (en) * 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
US20060105039A1 (en) 2004-10-21 2006-05-18 Jin-Wang Lai Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US20060105038A1 (en) * 2004-11-12 2006-05-18 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions prepared by coacervation
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
CN101309917B (zh) * 2005-10-06 2013-09-11 奥斯拜客斯制药有限公司 具有增强治疗性质的胃h+，k+-atp酶氘代抑制剂
BRPI0708601A2 (pt) * 2006-03-10 2011-06-07 Arigen Inc derivado de piridina, método para produzir um derivado de piridina, composição farmacêutica, agente anti-helicobacter pylori, e, agente profilático ou terapêutico para uma doença associada com helicobacter pylori
JP2009538901A (ja) * 2006-06-01 2009-11-12 デクセル ファーマ テクノロジーズ エルティーディー． 複式ユニット製薬的製剤
EP2023721A2 (de) * 2006-06-05 2009-02-18 Auspex Pharmaceuticals Inc. Herstellung und verwendung substituierter erythromycin-analoge
GB2459393B (en) 2006-10-05 2010-09-08 Santarus Inc Novel capsule formulation for the proton pump inhibitor omeprazole
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
WO2008057802A2 (en) 2006-10-27 2008-05-15 The Curators Of The University Of Missouri Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
BRPI1014314A2 (pt) * 2009-04-09 2019-09-24 Arigen Pharmaceuticals Inc derivado de tiopiridina, e, composição farmacêutica.
NZ600256A (en) 2009-12-02 2014-05-30 Aptalis Pharma Ltd Fexofenadine microcapsules and compositions containing them
US20110212171A1 (en) * 2010-01-08 2011-09-01 Eurand, Inc. Taste masked topiramate composition and an orally disintegrating tablet comprising the same
EP3288556A4 (de) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Oral zerfallende zusammensetzungen
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
WO2024075017A1 (en) 2022-10-04 2024-04-11 Zabirnyk Arsenii Inhibition of aortic valve calcification

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
JP2694361B2 (ja) * 1989-02-09 1997-12-24 アストラ アクチエボラグ 抗菌剤

Also Published As

Publication number Publication date
ES2066120T3 (es) 1995-03-01
CA2009741A1 (en) 1990-08-10
EP0382489B1 (de) 1994-11-17
DK0382489T3 (da) 1995-01-16
FI100168B (fi) 1997-10-15
US5013743A (en) 1991-05-07
DE69014141D1 (de) 1994-12-22
EP0382489A2 (de) 1990-08-16
NO900639D0 (no) 1990-02-09
EP0382489A3 (de) 1991-06-12
FI104045B (fi) 1999-11-15
DE69014141T2 (de) 1995-05-24
FI940951A0 (fi) 1994-02-28
FI104045B1 (fi) 1999-11-15
FI940951L (fi) 1994-02-28
GR3014973T3 (en) 1995-05-31
NO900639L (no) 1990-08-13
CA2009741C (en) 1999-03-23
FI900662A0 (fi) 1990-02-09

Similar Documents

Publication Publication Date Title
ATE114114T1 (de) Verwendung von benzimidazol-derivaten als antibakterielle mittel.
ATE215530T1 (de) 7-substituierte-8-substituierte-9-substituierte amino-7-demethyl-6-deoxy-tetracycline als antibiotische mittel
NZ228893A (en) Substituted quinoline and naphthyridine derivatives and pharmaceutical compositions
BG106390A (en) Novel spiro compounds
ATE82966T1 (de) Pyridincarboxamid-derivate und ihre verwendung als fungizides mittel.
DE60204452D1 (de) Pyrazolo[1,5]pyridinderivate
ATE227277T1 (de) Isoxazoline derivate und ihre verwendung als antimikroben
PT867436E (pt) Derivados de n-aril-piperidina e sua utilizacao como ligandos do receptor 5-ht1b
ATE113282T1 (de) Heteroaryl piperazine als antipsychotische mittel.
NO934718L (no) Nye HIV protease inhibitorer
DE69231422D1 (de) Pyridoncarbonsäurederivate
ATE159728T1 (de) Cis-epoxide derivate, verwendbar als irreversible hiv-protease inhibitoren und verfahren und zwischenprodukte zu ihrer herstellung
YU83993A (sh) Novi derivati piridon organske kiseline
ES2178765T3 (es) Nuevos derivados de 1,7,7-trimetil-biciclo (2.2.1) heptano.
ATE209633T1 (de) Pyridinderivate,als arzneimittel zur behandlung von geschwüren und als antibakterielle mittel
MXPA02011234A (es) Nuevas bases de oxidacion 2,5-diaminopiridina utiles para el tinte de las fibras queratinicas.
DE69017627D1 (de) Isochinolinderivate und ihre Salze als Proteasehemmer.
ATE275560T1 (de) Bemzimidazolverbindungen und medikamente die diese enthalten
DE69837628D1 (de) Aminderivate, verfahren zu ihrer herstellung und ihre verwendung als antimykotische mittel
DE69711506D1 (de) Methylsulfomycin 1, Verfahren zu dessen Herstellung und Verwendung
ATE222255T1 (de) 14-substituierte marcfortine und derivate als antiparasitäre mittel
DE69213049D1 (de) Isoquinolinderivate
ES2090056T3 (es) Derivados de pirroloquinolina, su utilizacion como agentes antimicrobianos y procedimientos para su preparacion.